Home/Hedge Fund Intelligence/ArriVent BioPharma, Inc.
Nasdaq: AVBPStockForm 13F30 Jun 2026

Hedge funds that hold ArriVent BioPharma, Inc. Nasdaq: AVBP

CUSIP 04272N102 · who reports it, how much, and how much it matters to them

20 of the 720 hedge fund managers we track reported shares of ArriVent BioPharma, Inc. (Nasdaq: AVBP) on Form 13F for 30 June 2026. Between them they reported USD 525m. The largest position belongs to Suvretta Capital Management, at USD 157m. The manager with the most riding on it is Octagon Capital Advisors, where it is 6.2% of the reported book.

Managers reporting it20of 720 we track
Value they reportUSD 525mshares only, 30 Jun 2026
Funds they run216with a file on PPLI.com
Largest positionUSD 157mSuvretta Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight6.2%Octagon Capital Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

20 managers, USD 525m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports ArriVent BioPharma, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Suvretta Capital Management4 funds on PPLI.comUSD 157m2.9%
2Orbimed Advisors1 fund on PPLI.comUSD 105m1.9%
3Octagon Capital Advisors1 fund on PPLI.comUSD 68m6.2%
4Sofinnova Investments1 fund on PPLI.comUSD 59m3.0%
5Logos Global Management1 fund on PPLI.comUSD 35m1.5%
6D. E. Shaw & Co.15 funds on PPLI.comUSD 30m0.0%
7POINT72 Asset Management17 funds on PPLI.comUSD 20m0.0%
8Millennium Management6 funds on PPLI.comUSD 15m0.0%
9Balyasny Asset Management25 funds on PPLI.comUSD 14m0.0%
10Acuta Capital Partners2 funds on PPLI.comUSD 7.6m5.3%
11Citadel Advisors32 funds on PPLI.comUSD 5.4m0.0%
12Burkehill Global Management5 funds on PPLI.comUSD 3.5m0.1%
13Two Sigma Investments35 funds on PPLI.comUSD 2m0.0%
14Tudor Investment Corporation10 funds on PPLI.comUSD 809,0000.0%
15Engineers Gate Manager1 fund on PPLI.comUSD 773,0000.0%
16Squarepoint Ops7 funds on PPLI.comUSD 609,0000.0%
17Persistent Asset Partners10 funds on PPLI.comUSD 547,0000.2%
18Jain Global1 fund on PPLI.comUSD 399,0000.0%
19Aquatic Capital Management3 funds on PPLI.comUSD 368,0000.0%
20Brevan Howard Capital Management39 funds on PPLI.comUSD 307,0000.0%
Next: where it matters most
Where it matters most

For Octagon Capital Advisors it is 6.2% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Octagon Capital AdvisorsUSD 68m6.2%
2Acuta Capital PartnersUSD 7.6m5.3%
3Sofinnova InvestmentsUSD 59m3.0%
4Suvretta Capital ManagementUSD 157m2.9%
5Orbimed AdvisorsUSD 105m1.9%
6Logos Global ManagementUSD 35m1.5%
7Persistent Asset PartnersUSD 547,0000.2%
8Burkehill Global ManagementUSD 3.5m0.1%
9POINT72 Asset ManagementUSD 20m0.0%
10Balyasny Asset ManagementUSD 14m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds ArriVent BioPharma, Inc.

What is the ticker symbol of ArriVent BioPharma, Inc.?

ArriVent BioPharma, Inc. trades under the symbol AVBP on the Nasdaq. Its CUSIP, the code used on Form 13F, is 04272N102.

Which hedge funds own ArriVent BioPharma, Inc. (Nasdaq: AVBP)?

20 of the 720 hedge fund managers PPLI.com tracks reported ArriVent BioPharma, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Suvretta Capital Management (USD 157m), Orbimed Advisors (USD 105m), Octagon Capital Advisors (USD 68m), Sofinnova Investments (USD 59m) and Logos Global Management (USD 35m).

How many hedge funds hold ArriVent BioPharma, Inc.?

20 managers in our coverage reported it, and between them they run 216 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on ArriVent BioPharma, Inc.?

Octagon Capital Advisors, where the position was 6.2% of the reported 13F book at 30 June 2026.

Does this show who is short ArriVent BioPharma, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with ArriVent BioPharma, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.